About Ceramide kinase
Ceramide kinase (CERK) is a protein
from Homo sapiens identified by UniProt accession
Q8TCT0, 537 residues long.
MolForge cross-references it against 0 known binders and
115 disease associations.
Target properties
| Protein name | Ceramide kinase |
| UniProt accession | Q8TCT0 |
| Gene | CERK |
| Organism | Homo sapiens |
| Length | 537 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (115)
Diseases linked to this target (Open Targets).
- body height · score 0.41
- appendicular lean mass · score 0.40
- neurodegenerative disease · score 0.25
- neoplasm · score 0.09
- triple-negative breast cancer · score 0.08
- breast cancer · score 0.06
- isolated agammaglobulinemia · score 0.06
- autosomal recessive severe congenital neutropenia due to JAGN1 deficiency · score 0.05
- X-linked severe congenital neutropenia · score 0.05
- immunodeficiency 53 · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TCT0-F1 | alphafold | PREDICTED | 88.42 | — |
Amino-acid sequence (537 residues)
MGATGAAEPL QSVLWVKQQR CAVSLEPARA LLRWWRSPGP GAGAPGADAC SVPVSEIIAV EETDVHGKHQ GSGKWQKMEK PYAFTVHCVK RARRHRWKWA QVTFWCPEEQ LCHLWLQTLR EMLEKLTSRP KHLLVFINPF GGKGQGKRIY ERKVAPLFTL ASITTDIIVT EHANQAKETL YEINIDKYDG IVCVGGDGMF SEVLHGLIGR TQRSAGVDQN HPRAVLVPSS LRIGIIPAGS TDCVCYSTVG TSDAETSALH IVVGDSLAMD VSSVHHNSTL LRYSVSLLGY GFYGDIIKDS EKKRWLGLAR YDFSGLKTFL SHHCYEGTVS FLPAQHTVGS PRDRKPCRAG CFVCRQSKQQ LEEEQKKALY GLEAAEDVEE WQVVCGKFLA INATNMSCAC RRSPRGLSPA AHLGDGSSDL ILIRKCSRFN FLRFLIRHTN QQDQFDFTFV EVYRVKKFQF TSKHMEDEDS DLKEGGKKRF GHICSSHPSC CCTVSNSSWN CDGEVLHSPA IEVRVHCQLV RLFARGIEEN PKPDSHS
Explore Ceramide kinase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets